Drug Comparison

PillID

Pill Identifier Drug Encyclopedia Drug Classes Interactions Blog 🌙

Prozac vs Zoloft: Key Differences

Prozac (fluoxetine) and Zoloft (sertraline) are both selective serotonin reuptake inhibitors (SSRIs) and two of the most prescribed antidepressants in the United States. While they share the same drug class and a broadly similar mechanism, they differ meaningfully in half-life, FDA-approved indications, drug interaction potential, and use in special populations. Understanding these differences helps clinicians — and patients — make more informed treatment decisions.

Quick Comparison

Feature	Prozac (Fluoxetine)	Zoloft (Sertraline)
Drug Class	SSRI	SSRI
Brand Names	Prozac, Sarafem	Zoloft
Half-Life	1–4 days; active metabolite norfluoxetine: 4–16 days	~26 hours
DEA Schedule	None	None
Pregnancy	Category C	Category C
Best For	Depression, OCD, bulimia, PMDD; preferred when medication adherence is a concern due to long half-life	Depression, OCD, PTSD, social anxiety disorder, panic disorder, PMDD; broadest FDA indication profile of any SSRI

How They're Similar

Both fluoxetine and sertraline work by blocking the serotonin transporter (SERT), preventing the reuptake of serotonin into the presynaptic neuron and thereby increasing serotonergic neurotransmission in the brain. This shared mechanism produces overlapping therapeutic effects: both are effective for major depressive disorder, generalized anxiety (often used off-label), OCD, and premenstrual dysphoric disorder (PMDD).

In clinical practice, the two drugs are often considered interchangeable starting points for depression and anxiety. Both typically require 4–8 weeks to reach full therapeutic effect. Side effect profiles are broadly similar — nausea, headache, insomnia or somnolence, and sexual dysfunction are common to both — and neither is a controlled substance. Both are available as inexpensive generics.

Key Differences

Half-Life and Discontinuation

Fluoxetine's exceptionally long half-life is its most pharmacologically distinctive feature. The parent drug has a half-life of 1–4 days, and its active metabolite norfluoxetine persists for 4–16 days. This means the drug essentially tapers itself when stopped, making discontinuation syndrome (brain zaps, flu-like symptoms, irritability) far less common or severe compared to sertraline and most other SSRIs. For patients who have a history of poor adherence or who are stopping medication, fluoxetine's pharmacokinetic profile is a genuine clinical advantage. Sertraline's 26-hour half-life is clinically typical for an SSRI and can produce noticeable discontinuation effects if stopped abruptly.

FDA-Approved Indications

Sertraline holds more FDA-approved indications than fluoxetine. Sertraline is approved for major depressive disorder, OCD, panic disorder, PTSD, social anxiety disorder, and PMDD. Fluoxetine is approved for major depressive disorder, OCD, panic disorder, bulimia nervosa, bipolar I depression (in combination with olanzapine), and PMDD. Notably, fluoxetine is the only SSRI FDA-approved for bulimia nervosa, while sertraline is the only SSRI FDA-approved for PTSD.

Pediatric Indications

Fluoxetine is FDA-approved for depression in children aged 8 and older and for OCD in children aged 7 and older. Sertraline is approved for OCD in children aged 6 and older, but is not FDA-approved for pediatric depression (though it is frequently used off-label).

Drug Interactions

Fluoxetine is a potent inhibitor of the CYP2D6 enzyme, which metabolizes a large number of commonly prescribed drugs including many antidepressants, antipsychotics, opioids, and antiarrhythmics. This makes fluoxetine a significant source of drug interactions and requires careful review of a patient's complete medication list. Sertraline is a weaker CYP2D6 inhibitor, producing fewer clinically meaningful interactions, and is often preferred in patients on complex medication regimens.

Prozac (Fluoxetine): Strengths & Weaknesses

Strengths

• Longest half-life of all SSRIs — greatly reduces discontinuation syndrome risk
• Approved for bulimia nervosa — the only SSRI with this indication
• Forgiving of missed doses
• Approved for pediatric depression (age 8+)
• Approved for bipolar depression in combination with olanzapine

Weaknesses

• Potent CYP2D6 inhibitor — significant drug interaction potential
• Long half-life can delay resolution of side effects if tolerability is an issue
• Not FDA-approved for PTSD or social anxiety disorder
• Norfluoxetine metabolite complicates switching to other serotonergic medications

Zoloft (Sertraline): Strengths & Weaknesses

Strengths

• Broadest FDA indication profile of any SSRI — including PTSD and social anxiety disorder
• Fewer drug interactions than fluoxetine (weaker CYP2D6 inhibition)
• Well tolerated — often considered the best-tolerated SSRI overall
• Approved for OCD in children 6 and older
• Widely studied and clinically familiar

Weaknesses

• Higher discontinuation syndrome risk than fluoxetine if stopped abruptly
• Not approved for bulimia nervosa
• Shorter half-life requires consistent daily adherence
• Not FDA-approved for pediatric depression

Which Is Right for You?

For patients with PTSD or social anxiety disorder, sertraline has clear FDA-backed evidence. For patients with bulimia nervosa or those with known adherence difficulties, fluoxetine's long half-life is a practical advantage. For patients on many other medications, sertraline's lower drug interaction burden is meaningful. Both are reasonable first-line choices for major depressive disorder and OCD, and individual response ultimately determines which works best.

Frequently Asked Questions